Literature DB >> 18602718

Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains.

Daniel Candotti1, Piotr Grabarczyk, Paola Ghiazza, Roberto Roig, Natalia Casamitjana, Paola Iudicone, Michael Schmidt, Arthur Bird, Robert Crookes, Ewa Brojer, Michelina Miceli, Azin Amiri, Chengyao Li, Jean-Pierre Allain.   

Abstract

BACKGROUND/AIMS: Nucleic acid testing (NAT) for hepatitis B virus (HBV) DNA in blood donations identified occult HBV infection (OBI) as a potential threat to blood safety.
METHODS: A collaborative study was undertaken to explore the molecular basis of OBIs prevalent in Europe in relation to clinical and serological data.
RESULTS: Ninety-one percent of 77 donor samples of European origin HBV DNA positive but HBV surface antigen (HBsAg) negative were confirmed. Viral load ranged between unquantifiable and 5640 IU/mL (median 25 IU/mL). Fifty-two strains were genotyped (14 HBV(A2) and 38 HBV(D)). Compared to HBsAg+ samples, genotype D was significantly more frequent than genotype A2 in OBIs from Poland or Italy (P<0.04). Amino acid substitutions were concentrated in the immunologically active parts of the Pre-S/S proteins (P<0.0001) affecting both cellular CD8 T-cell epitopes and B-cell neutralizing Major Hydrophilic Region epitopes. Substitutions were more frequent in OBIs than in HBsAg+ strains of both genotype D (P<0.001) and A2 (P<0.01), in OBIs of genotype D than A2 in the 'a' region (P<0.001) but not cellular epitopes, and in anti-HBs+ than anti-HBs- OBIs (P<0.001).
CONCLUSIONS: Results support the hypothesis that humoral and cellular immune pressure on the HBV envelope proteins are major mechanisms generating OBI.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18602718     DOI: 10.1016/j.jhep.2008.04.017

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  36 in total

1.  Hepatitis B virus (HBV) infection and recombination between HBV genotypes D and E in asymptomatic blood donors from Khartoum, Sudan.

Authors:  Shaza Mahgoub; Daniel Candotti; Magdy El Ekiaby; Jean-Pierre Allain
Journal:  J Clin Microbiol       Date:  2010-11-03       Impact factor: 5.948

Review 2.  Diagnostic algorithm for HBV safe transfusion.

Authors:  Jean-Pierre Allain; Daniel Candotti
Journal:  Blood Transfus       Date:  2009-07       Impact factor: 3.443

3.  Specific amino acid substitutions in the S protein prevent its excretion in vitro and may contribute to occult hepatitis B virus infection.

Authors:  Subhajit Biswas; Daniel Candotti; Jean-Pierre Allain
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

Review 4.  Molecular virology in transfusion medicine laboratory.

Authors:  Daniel Candotti; Jean-Pierre Allain
Journal:  Blood Transfus       Date:  2012-12-21       Impact factor: 3.443

5.  Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.

Authors:  Xianlin Ye; Tong Li; Xiaoxuan Xu; Peng Du; Jinfeng Zeng; Weigang Zhu; Baocheng Yang; Chengyao Li; Jean-Pierre Allain
Journal:  Blood Transfus       Date:  2016-05-17       Impact factor: 3.443

Review 6.  Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus.

Authors:  Venkatakrishna Shyamala
Journal:  Asian J Transfus Sci       Date:  2014-01

7.  Characterization of occult hepatitis B virus infection from blood donors in China.

Authors:  Xin Zheng; Xianlin Ye; Ling Zhang; Wenjing Wang; Lifang Shuai; Anqi Wang; Jinfeng Zeng; Daniel Candotti; Jean-Pierre Allain; Chengyao Li
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

8.  Molecular characteristics of occult hepatitis B virus from blood donors in southeast China.

Authors:  Quan Yuan; Shan-Hai Ou; Chang-Rong Chen; Sheng-Xiang Ge; Bin Pei; Qing-Rui Chen; Qiang Yan; Yong-Cai Lin; Hong-Ying Ni; Cheng-Hao Huang; Anthony E T Yeo; James W K Shih; Jun Zhang; Ning-Shao Xia
Journal:  J Clin Microbiol       Date:  2009-11-25       Impact factor: 5.948

9.  Surface antigen-negative hepatitis B virus infection in Dutch blood donors.

Authors:  R W Lieshout-Krikke; M W A Molenaar-de Backer; P van Swieten; H L Zaaijer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-13       Impact factor: 3.267

10.  Mutations associated with occult hepatitis B in HIV-positive South Africans.

Authors:  Eleanor A Powell; Maemu P Gededzha; Michael Rentz; Nare J Rakgole; Selokela G Selabe; Tebogo A Seleise; M Jeffrey Mphahlele; Jason T Blackard
Journal:  J Med Virol       Date:  2014-08-27       Impact factor: 2.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.